Aurum Healthcare, a sterilisation services provider for medical devices and instruments, has been acquired by Accuron Technologies, which purchased a majority stake in the company to fully-integrate its suite of medical device outsourcing services.

Following the transaction, Aurum will become part of Accuron’s Advanced Materials Technologies (AMT). The acquisition will add Aurum’s 20,000ft² facility in Johor Bahru, Malaysia, to AMT’s existing manufacturing footprint of 120,000ft² facilities located in Singapore and China.

Merit Medical Systems has completed its acquisition of DFine, an American medical device company specialising in minimally-invasive therapeutic devices, for a cash consideration of $97.5m.

"The related sales divisions will be restructured to focus more on its broad portfolio of products."

Following the acquisition, Merit’s oncology segments including embolics, microcatheters and biopsy products will be combined into a newly-created interventional oncology and spine division (IOS). The related sales divisions will be restructured to focus more on its broad portfolio of products.

Shanghai Runda Medical Technology intends to acquire 45% stake in Hangzhou Yi Dan Biotechnology from Hangzhou Yee Wo Investment Management Partnership, for CNY216m ($32.45m).

All the three companies involved in the transaction are based in China.